Working… Menu
Trial record 1 of 2 for:    Covid | Immunotherapy | Canada
Previous Study | Return to List | Next Study

Cellular Immuno-Therapy for COVID-19 Acute Respiratory Distress Syndrome (CIRCA-19)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04400032
Recruitment Status : Completed
First Posted : May 22, 2020
Last Update Posted : April 26, 2021
Stem Cell Network
Ontario Research Fund
Information provided by (Responsible Party):
Ottawa Hospital Research Institute

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : April 22, 2021
Actual Study Completion Date : April 22, 2021